Left circumflex occlusion in acute myocardial infarction (from the National Cardiovascular Data Registry)

W Kyle Stribling1, Michael C Kontos, Antonio Abbate

  • 1Virginia Commonwealth University, Richmond, USA. wkstrib@yahoo.com

Insights

Acute left circumflex artery occlusion often presents without ST-elevation myocardial infarction (STEMI). Patients with non-STEMI (NSTEMI) LCx occlusion have lower in-hospital mortality than those with STEMI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Acute left circumflex (LCx) artery occlusion typically presents with ST-segment elevation less than 50% of the time, potentially delaying treatment.
  • Limited contemporary data exists on the clinical outcomes of patients with LCx territory occlusion who do not have ST-segment elevation myocardial infarction (STEMI).

Purpose of the Study:

  • To compare clinical outcomes, including in-hospital mortality, between patients with STEMI and non-STEMI (NSTEMI) due to acute LCx territory occlusion.
  • To identify factors influencing outcomes in LCx occlusion presenting as STEMI versus NSTEMI.

Main Methods:

  • Retrospective analysis of 27,711 patients with myocardial infarction and acute LCx territory occlusion treated with percutaneous coronary intervention (PCI) from April 2004 to June 2009.
  • Exclusion of patients with prior coronary artery bypass grafting.
  • Logistic generalized estimating equation modeling was used to compare outcomes between STEMI and NSTEMI groups, adjusting for baseline characteristics.

Main Results:

  • Of 27,711 patients, 67% presented with STEMI and 33% with NSTEMI.
  • Patients with STEMI were more likely to have proximal LCx culprit lesions (63% vs 27%).
  • Risk-adjusted in-hospital mortality was significantly greater in the STEMI group compared to the NSTEMI group (OR 1.36, 95% CI 1.12-1.65).

Conclusions:

  • Acute LCx territory occlusion frequently presents as NSTEMI.
  • Patients with NSTEMI LCx occlusion exhibit a lower in-hospital mortality risk compared to those with STEMI.
  • Potential contributing factors to lower NSTEMI mortality include myocardium involved, lesion location, and dual blood supply.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...